InPheno AG in Liquidation
Company Overview
Previous Company Names
- DIAGENE AG
- DiaGene AG
- InPheno AG
- (InPheno SA) (InPheno Ltd)
Management
Thomas Klimkait
Lörrach, DE
Chairperson of the board
Individual signing authority
Hans Zimmermann
Basel
Member of the board
Individual signing authority
Prof. Moroni
Biel-Benken
Chairperson of the board
Joint signing authority (any two to sign)
Peter Erb
Basel
Member of the board
Joint signing authority (any two to sign)
André Miserez
Aesch
Member of the board
Joint signing authority (any two to sign)
Derek Brandt
Oberdorf
Member of the board
Joint signing authority (any two to sign)
Peter Koch
Therwil
Member of the board
Joint signing authority (any two to sign)
Etienne Bernath
Zollikon
Joint signing authority (any two to sign)
Thomas Klimkait
Lörrach
Joint signing authority (any two to sign)
Catharina Maulbecker
Zürich
Member of the board
Joint signing authority (any two to sign)
Jost Harr
Oberwil BL
Member of the board
Joint signing authority (any two to sign)
Claudio Schmid
Arlesheim
General manager
Joint signing authority (any two to sign)
Heinrich Zinsli
Münchenstein
Member of the board
Joint signing authority (any two to sign)
Peter Burckhardt
Basel
Member of the board
Joint signing authority (any two to sign)
François Hamy
Illzach (FR)
Joint signing authority (any two to sign)
Building smart people network graph...
Fetching people and their companies
Address & Locations
Primary Address
Loading map...
| No. | Journal No. | Journal date | SOGC | SOGC date | Page / ID |
|---|---|---|---|---|---|
| 1 | 3559 | 21.05.2021 | 100 | 27.05.2021 | 1005194204 |
| 2 | B7570 | 22.12.2020 | B252 | 28.12.2020 | 1005059511 |
| 3 | B3129 | 02.06.2020 | B107 | 05.06.2020 | 1004903809 |
| 4 | 4535 | 14.08.2015 | 159 | 19.08.2015 | 2328441 |
| 5 | 2104 | 21.04.2015 | 78 | 24.04.2015 | 2117869 |
| 6 | 5879 | 22.10.2013 | 207 | 25.10.2013 | 1146949 |
| 7 | 5062 | 10.09.2013 | 177 | 13.09.2013 | 1075885 |
| 8 | 6898 | 19.08.2009 | 163 | 25.08.2009 | 7/5212544 |
| 9 | 3477 | 19.06.2008 | 121 | 25.06.2008 | 6/4541802 |
| 10 | 3717 | 04.07.2007 | 131 | 10.07.2007 | 5/4016900 |
Company Purpose
Forschung und Entwicklung von Produkten sowie Erbringung von Dienstleistungen für die forschende pharmazeutische und biotechnologische Industrie sowie für molekulare Diagnostik und medizinische Therapie. Die Gesellschaft kann Rechte erwerben und Lizenzen verwerten, sich an gleichen oder ähnlichen Betrieben beteiligen und solche gründen sowie Liegenschaften erwerben, verwalten und veräussern.